Faculty Opinions recommendation of Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
2015 ◽
Vol 16
(4)
◽
pp. 465-474
◽
1997 ◽
Vol 98
(1)
◽
pp. 140-146
◽
2006 ◽
Vol 133
(4)
◽
pp. 382-388
◽
2001 ◽
Vol 15
(2)
◽
pp. 99-103
◽
2001 ◽
Vol 114
(2)
◽
pp. 281-289
◽
The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia
1989 ◽
Vol 73
(2)
◽
pp. 173-180
◽
2010 ◽
Vol 84
(2)
◽
pp. 117-127
◽